To Cancer : Complementary and Integrative Therapies of Cancer.

The reported mortality rate for this cancer in the United States is 2.5 per 100,000 women, but some countries in Latin America is ten times higher, experts say

The registration of 30,000 deaths per year in Latin America for cervical cancer, caused by human papilloma virus, can bend if not covered by the vaccine to prevent it, said an expert from the Pan American Health Organization (PAHO).

The Regional Adviser Expanded Immunization Program of PAHO, Cuauhtemoc Ruiz, told Efe that this is the record of deaths in the region by the disease, but considering the underreporting that may have “this number is much higher .

“If we do nothing to prevent infections that are occurring at this time, we will have to double by 2030 deaths from this cause in our countries,” said Ruiz, who attended the launch in Panama vaccination campaign against Human Papillomavirus (HPV).

The vaccine, which is to be effective must be applied before initiating sexual activity, is inoculated into Panama to girls 10 years old, during the first year free on a Latin American country.

The reported mortality rate for this cancer in the United States is 2.5 per 100,000 women, but some countries in Latin America is “ten times higher,” said the expert who identified the highest rates in Central , the Caribbean and the South American continent.

The HPV vaccine, along with that of rotavirus and pneumococcus, three inoculations of new countries in the region begin to introduce into their immunization programs.

To incorporate the vaccine is required of any scientific training, technology, human resources and financial sustainability, “and PAHO is responsible for making this kind of support and study together with the countries,” said Ruiz.

Last September, at the board meeting of PAHO, the countries of the region adopted the strategy for the prevention and control of cervical cancer “that establishes the mechanisms for the introduction of this vaccine in the shortest time possible,” added the source.

“This vaccine ensures that approximately 70% of all HPV infections are usually recorded in adolescence are prevented in Panama,” said Ruiz.

He noted that his application “has nothing to do with encouraging or promoting debauchery sexual life at an earlier age,” as some critics say.

He explained that according to recent international studies, “there is no evidence to speak of risk by the application of this vaccine.”

The inoculation has been approved and registered in 59 countries in Latin America at 15. Panama is the first to apply the three doses needed to immunize a 100 percent against this disease.

Comments are closed.